Literature DB >> 17986139

Regulation of axonal development by plasma membrane gangliosides.

José Abad-Rodriguez1, Andrea Robotti.   

Abstract

Gangliosides present in the plasma membrane participate in fundamental processes during neuronal development. From the determination and the outgrowth of the axon, to the growth inhibitory activity produced after CNS injury, local interconversion of these glycosphingolipids regulate actin dynamics in a spatially restricted manner by modulating membrane receptors and their downstream signaling pathways. Here, we will review the possible mechanisms underlying these modulations and the potential importance of gangliosides and ganglioside-transforming enzymes as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986139     DOI: 10.1111/j.1471-4159.2007.04713.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

Review 1.  Sweet complementarity: the functional pairing of glycans with lectins.

Authors:  H-J Gabius; J C Manning; J Kopitz; S André; H Kaltner
Journal:  Cell Mol Life Sci       Date:  2016-03-08       Impact factor: 9.261

2.  Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Authors:  Zhuji Fu; Chen Chen; Joseph T Barbieri; Jung-Ja P Kim; Michael R Baldwin
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

Review 3.  Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

Authors:  Mauro Maccarrone; Manuel Guzmán; Ken Mackie; Patrick Doherty; Tibor Harkany
Journal:  Nat Rev Neurosci       Date:  2014-12       Impact factor: 38.755

4.  Genotoxicity Study of Glycopeptide (G-7%NANA).

Authors:  Ha-Young Kim; Min-Hee Kim; Hee-Kyong Kim; Yeong-Chul Park
Journal:  Toxicol Res       Date:  2018-07-15

5.  Neu3 sialidase-mediated ganglioside conversion is necessary for axon regeneration and is blocked in CNS axons.

Authors:  Sunil Kappagantula; Melissa R Andrews; Menghon Cheah; José Abad-Rodriguez; Carlos G Dotti; James W Fawcett
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.